Early preimplantation embryos are sensitive to external osmolarity and use novel mechanisms to accumulate organic osmolytes and thus control their cell volumes and maintain viability. However, these mechanisms are restricted to the cleavage stages of development, and it was unknown whether postcompaction embryos use organic osmolytes. Mouse embryos developing from the 8-cell stage formed blastocoel cavities in vitro at osmolarities up to 360 mOsM. Above this range, several putative organic osmolytes (alanine, glutamine, glycine, and beta-alanine) rescued blastocyst development, but several effective osmoprotectants in cleavage-stage embryos (such as betaine and proline) did not. At physiological osmolarities, each of these compounds resulted in significantly larger blastocysts. This was not due to increased cell numbers, which were unaffected in blastocysts by osmolarity in the range where blastocyst size was rescued by potential organic osmolytes, although cell number was decreased at higher osmolarities and was rescued by each osmolyte. The effective osmolytes were accumulated intracellularly by embryos developing in vitro from the 8-cell stage to blastocysts. However, unlike conventional organic osmolytes in somatic cells or those in cleavage-stage embryos, their intracellular concentrations were not increased with increasing external osmolarity. With the exception of betaalanine, which is taken up via the beta-amino acid transport system, the effective osmolytes were transported by the B 0,+
INTRODUCTION
Very early preimplantation mouse embryos are particularly sensitive to increased osmolarity in vitro. Fertilized eggs from females of most genetic backgrounds will not develop in culture even in media whose osmolarity is the same as that of their in vivo environment in the oviduct [1] but instead become arrested at the 2-cell stage [2] . One way to rescue development in vitro is to reduce medium osmolarity. However, it has also been shown that the presence of any of several amino acids or their derivatives in the medium will rescue complete preimplantation development to the blastocyst stage in vitro at physiological osmolarity [3] . These include glycine, betaine (N,N,N-trimethylglycine), b-alanine, glutamine, and proline [3] [4] [5] [6] [7] [8] .
These diverse compounds are able to rescue embryo development from the fertilized egg because each can function as an organic osmolyte. Mammalian cells regulate their volumes osmotically by importing and exporting intracellular osmolytes to adjust intracellular osmotic pressure and hence maintain size. The first line of defense against an unwanted volume decrease is to import inorganic ions [9] . However, in a range of cell types that are subjected to chronic hypertonicity, the increased intracellular ionic strength caused by the amount of accumulated ions needed to sustain cell size is detrimental to cell viability. In these cases, such cells have the ability to accumulate small uncharged compounds collectively termed organic osmolytes, which replace a portion of the intracellular ions, thus reducing ionic strength, while still maintaining cell volume [10, 11] .
Although some organic osmolytes are synthesized intracellularly, most are taken up from the external environment by specialized organic osmolyte transporters [9, 12] . Mammalian somatic cells have four such transporters. These are 1) the system A transporter, which corresponds to the ATA2 protein (officially known as SLC38A2) that accepts a range of small uncharged amino acids; 2) BGT1 transporter (SLC6A12), which transports betaine; 3) the b-amino acid transporter TAUT (SLC6A6); and 4) the Na þ -myoinositol transporter, SMIT (SLC5A3) [12] [13] [14] [15] [16] [17] .
The precompaction embryo, however, does not accumulate organic osmolytes by the same mechanisms used by somatic cells. One of the somatic organic osmolyte transporters, the bamino acid transporter, is expressed throughout preimplantation development [18] . However, it appears to have at best a secondary role in cleavage-stage embryos in osmoprotection by transporting b-alanine and instead may mainly serve to transport taurine for other functions [7] . Neither the BGT1 betaine transporter SLC6A12 [8, 19, 20] nor the system A transporter SLC38A2 [21, 22] is expressed in precompaction embryos. Finally, myoinositol, whose transporter SLC5A3 is present and becomes highly active in blastocysts [23] , is not osmoprotective in precompaction mouse embryos [3] .
The very early embryo has instead developed a unique set of cell volume regulatory mechanisms. The major one depends on the intracellular accumulation of glycine to high levels, mediated by activity of the classic GLY transport system corresponding to the SLC6A9 protein (commonly known as GLYT1) [24] . Transport and osmosensitive intracellular accumulation of glycine via SLC6A9 permit 1-cell mouse embryos to develop at osmolarities near those of their normal oviductal environment and to maintain their normal cell volume [24] [25] [26] . It has recently been shown that glycine transport activity and glycine-mediated cell volume regulation are activated in the oocyte at ovulation [27] . This oocyte-and embryo-specific mechanism of volume homeostasis then functions only during a restricted period of preimplantation development, ending by the 4-to 8-cell stage [22, 27, 28] .
Another mechanism accounts for the ability of betaine and proline to rescue development of fertilized mouse eggs at increased osmolarity [8] . This has recently been identified as the SIT1 transporter (officially known as SLC6A20A) [19, 20] . Because glycine is very abundant in oviductal fluid [29, 30] and in eggs and early embryos [27, 31] , betaine and/or proline may have a supporting role in cell volume homeostasis in early embryos. SIT1-type transport is even more developmentally restricted than glycine transport via SLC6A9, being activated by fertilization and becoming inactive by the 4-cell stage [20] .
Thus, oocytes during meiotic maturation and preimplantation embryos before compaction at the 8-cell stage have unique mechanisms of cell volume homeostasis not found in somatic cells. It is unknown, however, what regulates cell volume in preimplantation embryos after compaction, when both the glycine-dependent and betaine/proline-dependent mechanisms have been inactivated. We hypothesize that postcompaction embryos may continue to use organic osmolytes but that these will not necessarily be the same as those used by oocytes and cleavage-stage embryos and that they will be accumulated in embryos via different transporters.
MATERIALS AND METHODS

Chemicals and Media
All chemicals were obtained from Sigma (St. Louis, MO) unless otherwise noted. Culture media were based on potassium simplex optimized medium (KSOM) [32] , modified by omitting glutamine and replacing bovine serum albumin with polyvinyl alcohol (1 mg/ml of cold water-soluble MW 30-70K) and designated as mKSOM. The mKSOM was equilibrated with 5% CO 2 in air at 378C. Similarly modified Hepes-KSOM (Hepes-mKSOM), adjusted to pH 7.4, was used for oocyte and embryo collection and where specified. Potential organic osmolytes were prepared as 1003 stocks in water and stored at À208C until used. Medium osmolarity was measured using a vapor pressure osmometer (Vapro 5520; Wescor, Logan, UT). Osmolarity was increased above 250 mOsM (to within 65 mOsM of nominal value) using the trisaccharide D(þ)-raffinose [3] . Acid Tyrode solution was mouse embryo tested and purchased from Sigma. The GLYT1 transport inhibitor ORG23798 (bis [4-fluorophenyl] methylenepiperidineacetic acid, lithium salt) was synthesized at Organon Laboratories (Cambridge, England) as previously described [24] , prepared as a 10003 stock in dimethyl sulfoxide, and stored at À208C until used. 3 
Embryos and Embryo Culture
Embryos were obtained from female CF1 mice (aged 4-7 wk, Charles River Canada; St-Constant, PQ) that had been superovulated by i.p. injection of equine chorionic gonadotropin (5 IU), followed approximately 47 h later by i.p. injection of human chorionic gonadotropin (hCG) (5 IU). The female mice were caged overnight with BDF 1 males (Charles River Canada) immediately after hCG injection for mating. All procedures were approved by the Animal Care Committee of the Ottawa Hospital Research Institute. Eight-cell embryos were obtained by flushing oviducts at approximately 67 h after hCG injection. Embryos were cultured in standard microdrop cultures under mineral oil at FIG. 1. Development of 8-cell mouse embryos to blastocysts as a function of osmolarity. Eight-cell embryos were cultured for 3 days in mKSOM medium, and the percentage reaching the morula stage after 1 day (A) and the blastocyst stage after 2 days (B) or 3 days (C) was scored. Data were arcsine transformed before analysis by ANOVA, followed by Tukey-Kramer post hoc test. Points that do not share the same letter within each panel are significantly different (P , 0.05). Each point represents the mean 6 SEM of three to five repeats, with 10-15 embryos per repeat, for a total of 35-72 embryos per repeat.
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378C in 5% CO 2 in air. At 1, 2, and 3 days of culture from the 8-cell stage, embryos were photographed using an Axiovert IM35 microscope fitted with Hoffman optics (Zeiss, Welwyn Garden City, England) with a 203 objective and Nikon (Natick, MA) Coolpix 4500. The number of embryos reaching the morula stage after 1 day and the blastocyst stage after 2 or 3 days was scored and recorded. Experiments were continued for 3 days because embryos in culture, particularly when stressed, develop more slowly than in vivo.
Transport and Accumulation Measurements
For measurements of 3 H-labeled amino acid content, embryos were rinsed three times in equilibrated medium in groups of four to 10 and transferred to preequilibrated mKSOM containing the radiolabeled amino acid for the specified period. They were then washed five times in ice-cold Hepes-mKSOM and transferred to a scintillation vial and scintillation fluid added as previously described [19, 24] . A similar volume of the last wash drop was transferred to a separate vial to obtain background that was subtracted from each paired measurement.
3 H measurements were done in 4-ml volumes of scintillation fluid using a model 2200CA TriCarb liquid scintillation counter (Packard Instrument Co., Downer's Grove, IL), with each sample counted for 5 min. A standard curve was constructed for each set of experiments by serial dilutions of the radiolabeled compounds in water for conversion of counts per minute to molar amounts of labeled amino acid. The amount of amino acid accumulated by embryos over 3 days of culture from the 8-cell to blastocyst stages was determined by culturing the embryos with 1 mM 3 H-labeled alanine, glutamine, or glycine (specific activity reduced 1000-fold from stock by mixing 1:1000 with unlabeled amino acid to prevent toxicity). Blastocysts were mechanically collapsed before washing to eliminate any labeled amino acid that might be trapped in the blastocoel cavity. The total accumulated radiolabeled amino acid was expressed as picomoles per embryo.
Rates of transport of alanine, glutamine, glycine, or taurine by morulae were determined by incubating them for 10 min with 1 lM 3 H-labeled amino acid. The rate of transport was calculated by dividing the total molar amount of radiolabeled amino acid in the sample by the number of embryos and the 10-min incubation period and were expressed as femtomoles per embryo per minute as previously described [19, 24] . Potential competitive inhibitors of transport
Partial rescue of development of 8-cell mouse embryos to blastocysts in 400 mOsM medium by potential organic osmolytes. Eight-cell embryos were cultured for 3 days in mKSOM medium, and the percentage reaching the morula stage after 1 day (Mor) and the blastocyst stage after 2 days (Bl 2) or 3 days (Bl 3) of culture was scored. Each panel shows a set of cultures that tested the effect of a possible organic osmolyte present at 1 mM on development, showing development at 250 mOsM, 400 mOsM, and 400 mOsM in the presence of the potential osmolyte (inset keys). Of the compounds tested, statistically significant rescue of development was seen after 2 or 3 days of culture for alanine, glutamine, and glycine (*P , 0.05 and **P , 0.01 by Student t-test for difference between the presence and absence of tested osmolyte at 400 mOsM after arcsine transformation). Each bar is the mean 6 SEM of five repeats, with six to 15 embryos per culture drop, for a total of 39-75 per treatment group.
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(unlabeled) were included where specified at a concentration of 10 mM (i.e., 10 000-fold excess). The glycine transporter inhibitor ORG23798 was used at a maximally effective concentration of 5 lM as previously described [24] .
Determining Embryo Volume, Cell Number, and Apoptotic Nuclei Embryo volumes were determined by measuring the major and minor radii (ImageJ; National Institutes of Health, Bethesda, MD) at an equatorial plane of focus. We then calculated the volume of the embryo, assumed to be a prolate ellipsoid.
Total cell numbers were determined by staining with bisbenzimide [33] . Briefly, embryos were placed in acid Tyrode solution for 5-15 sec until the zona pellucida was easily removed, washed, and incubated for 30 min at 378C with 50 lg/ml of bisbenzimide in Hepes-mKSOM. The embryos were then washed and placed in a well made from transparent tape on a glass slide, compressed with a coverslip, and sealed with nail polish. Stained nuclei were visualized and counted on an inverted fluorescence microscope using a standard bisbenzimide filter set.
To determine the proportion of nuclei with fragmented DNA that are likely apoptotic, blastocysts were fixed and permeabilized (2% formaldehyde and 0.02% Triton X-100 in Dulbecco PBS), TUNEL labeled for DNA nicked ends (In Situ Cell Death Detection Kit; Roche Applied Science, Laval, PQ), and costained with 1 mg/ml of propidium iodide for total nuclei. Confocal imaging through the entire blastocyst was used to determine the number of TUNELpositive nuclei and total nuclei. Data were expressed as the percentage of TUNEL-positive nuclei in each blastocyst. Blastocysts that were treated with 1 U/ml of DNase I (Promega, Madison, WI) at 378C for 10 min after they had been fixed and permeabilized served as a positive TUNEL control.
Data Analysis
Embryo development data are presented as the mean percentage of embryos reaching the stated developmental stage. The SEMs are shown on graphs as an indication of variance but were not used for statistical analysis. Instead, development data were arcsine transformed before analysis using Student t-test or ANOVA and Tukey multiple comparisons test. All other data are presented as the mean 6 SEM and were analyzed using ANOVA and Tukey multiple comparisons test. Graphing was done using Prism 5.02 (GraphPad Software, La Jolla, CA) and statistical analysis by Prism 5.02 or InStat 2.04 (GraphPad Software).
RESULTS
Effect of Increased Osmolarity and Potential Organic Osmolytes on Development of 8-Cell Embryos In Vitro
We first sought to determine the threshold osmolarity above which development of 8-cell embryos to blastocysts was impaired in mKSOM that contained no potential organic osmolytes. Embryos were cultured for 3 days at osmolarities ranging from 290 to 450 mOsM. There was no major effect on development to the morula stage over this range of osmolarities (Fig. 1A) . Blastocyst development after either 2 or 3 days was not significantly affected at osmolarities up to 360 mOsM, but the proportion developing to blastocysts decreased sharply at 370-380 mOsM, while there was no blastocyst formation at 400 mOsM or above (Fig. 1, B and C) .
Based on these results, we chose 400 mOsM as a test osmolarity at which to initially screen for the ability of potential organic osmolytes to rescue development from the 8-cell stage to blastocysts. The strategy was to choose highly detrimental conditions where blastocyst development was completely blocked and to assess compounds for an ability to support even a few embryos to develop to blastocysts. Successful compounds would then be tested over a full range of osmolarities. The following eight possible osmolytes were tested: alanine, b-alanine, betaine, glutamine, glycine, myoinositol, proline, and taurine (all added to mKSOM at 1 mM). Betaine, glutamine, glycine, and proline were chosen because of their functions as organic osmolytes in cleavage-stage embryos, while the others are principal organic osmolyte substrates of the following somatic cell organic osmolyte transporters: b-amino acid transporter (taurine and b-alanine), Na þ -myoinositol transporter (myoinositol), system A (alanine), and BGT1 (betaine). Of the compounds tested, alanine, glutamine, and glycine significantly rescued blastocyst development at 400 mOsM, while the others had no significant effect (Fig. 2 ). These were thus chosen for further experiments, as they were likely to have the most robust osmoprotective effects that would be more fully evident at lower osmolarities.
Because previous work at the 1-cell stage had shown that balanine had a maximally protective effect at 5 mM but little effect at 1 mM, unlike the other effective organic osmolytes that were maximally protective well below 1 mM [3, 8, 24] , we also tested b-alanine herein at 5 mM. Five millimolar b- alanine   FIG. 3 . Effect of organic osmolytes on development of 8-cell embryos to blastocysts as a function of osmolarity. Eight-cell embryos were cultured for 3 days in mKSOM medium (250 mOsM) or medium adjusted to 310, 340, 370, and 400 mOsM, with no addition (Control) or with 1 mM alanine, glutamine, or glycine or 5 mM b-alanine (inset key). The percentage reaching the morula stage after 1 day (A) and the blastocyst stage after 2 days (B) or 3 days (C) was scored. Development was tested for significant difference between treatments within each osmolarity on each day (*P , 0.05, **P , 0.01, and ***P , 0.001 by ANOVA, followed by Tukey-Kramer post hoc test after arcsine transformation). Where the control group is marked by asterisks, control is significantly different from all other groups. Where brackets are used, the difference is significant between control and the group(s) indicated by the end of the bracket. Each bar is the mean 6 SEM of three repeats, with 36-45 embryos total in each.
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significantly rescued development to the blastocyst stage at 400 mOsM (29% after 2 days [P , 0.001] and 53% after 3 days [P , 0.05] vs. 0% with no addition [three repeats]) (data not shown). Thus, we also included a group with 5 mM b-alanine in subsequent experiments.
To reveal the range of osmolarities over which these putative organic osmolytes were osmoprotective, we then assessed morula development after 1 day and blastocyst development after 2 and 3 days in culture from 8-cell embryos in mKSOM with no addition or with alanine, glutamine, or glycine (1 mM) or b-alanine (5 mM) at 250-400 mOsM (Fig.  3) . Development to the morula stage was unaffected over this range of osmolarities (Fig. 3A) . Development to the blastocyst stage after 2 or 3 days, however, was completely rescued by the presence of any of these compounds up to 370 mOsM, at which osmolarity, in contrast, there was little development in mKSOM without any additions (Fig. 3, B and C) .
Effect of Organic Osmolytes on Blastocyst Volume, Cell Number, and Apoptotic Nuclei
When development to the blastocyst stage was assessed, alanine, glutamine, glycine, and b-alanine only exhibited apparent osmoprotective effects (Fig. 3, B and C) at osmolarities that were greater than the reported physiological levels in vivo (the in vivo osmolarity is reportedly approximately 330 mOsM [see Discussion]). However, the metric used for those assessments was development of any visible blastocoel cavity regardless of its size. To determine whether there were subtler effects on blastocyst development evident at more physiological osmolarities, we measured the total volume and total cell number in blastocysts at different osmolarities in the presence or absence of added organic osmolytes. The addition of alanine, glutamine, glycine, or b-alanine had no effect on total blastocyst volume at 250 mOsM. However, FIG. 4 . Volume, total cell number, and apoptotic nuclei in blastocysts with and without osmolytes. A and B) Volume of blastocysts were measured after 2 days (A) or 3 days (B) in culture from the 8-cell stage with no addition (none) or potential osmolytes present (1 mM each except 5 mM for b-alanine), as indicated by inset key, as a function of osmolarity. Each point represents the mean 6 SEM of three independent repeats. For each repeat, the mean volume of all blastocysts in a culture drop was treated as a single measure, so that statistical tests were performed with n ¼ 3 for each treatment group. The total number of embryos in each treatment group was 36-45. Points marked by an asterisk are different from no addition at the same osmolarity, while there were no significant differences between other treatment groups (P , 0.05 by ANOVA with Tukey-Kramer post hoc test). No analysis was performed at 400 mOsM because no blastocysts developed in some groups (volumes are the mean of remaining blastocysts). C and D) Total cell counts were performed on blastocysts cultured for 2 days at 310 mOsM (C) or 370 mOsM (D) with no addition (none) or potential osmolytes present (as in A). Bars that do not share the same letter are significantly different (P , 0.05 by ANOVA with Tukey post hoc test). Each point represents the mean 6 SEM of 15 (C) or nine (D) blastocysts in total from three independent repeats. E) Embryos were cultured for 2 days from the 8-cell stage to blastocysts, fixed, and apoptotic nuclei detected by TUNEL labeling. Culture was in 250, 340, or 370 mOsM media in the presence or absence of 1 mM glycine, as indicated at the bottom. Each bar represents the mean 6 SEM percentage of TUNEL-positive nuclei in a total of five to seven independent repeats, each with five to nine blastocysts, for a total of 32-53 blastocysts per group (data were left as percentage because Bartlett test indicated no significant differences between variances). Bars sharing the same letters are not significantly different (P , 0.05 by ANOVA with Tukey-Kramer post hoc test).
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blastocyst size was significantly increased by the presence of any of these organic osmolytes after 2 days in culture at 310 or 340 mOsM (Fig. 4A) or after 3 days at 310, 340, or 370 mOsM (Fig. 4B) , indicating that organic compounds rescue blastocyst expansion at physiological osmolarity.
The difference in blastocyst volumes could be due at least in part to differences in the number of cells. However, total cell number (after 2 days in culture) was unaffected by the presence or absence of organic osmolytes at 310 mOsM (Fig. 4C) . In contrast, at 370 mOsM, cell number significantly decreased in the absence of organic osmolytes and was rescued by the presence of any of these compounds (Fig. 4D) .
The difference in cell number at 370 mOsM could be due to increased cell death by apoptosis. Thus, the proportion of apoptotic nuclei in blastocyst was assessed after 2 days in culture at 250, 340, and 370 mOsM (Fig. 4E) . Cultured embryos at 250 mOsM had about 9% TUNEL-positive nuclei, which was higher than in blastocysts that had developed in vivo (approximately 4% [data not shown]), likely reflecting the previously reported increased apoptosis in cultured vs. in vivoderived blastocysts [34] . Increasing osmolarity from 250 to 340 or 370 mOsM significantly increased the fraction of TUNELpositive nuclei in cultured blastocysts. However, glycine, which rescues blastocyst development, volume, and cell number (Figs. 3 and 4, A-D) , did not significantly reduce the proportion of apparently apoptotic nuclei at increased osmolarities (Fig. 4E ).
Accumulation and Transport of Potential Organic Osmolytes
For any compound added to the external medium to function as an organic osmolyte, it must be taken up into the cell. Thus, we used 3 H-labeled alanine, glutamine, or glycine (1 mM each) to determine if they were accumulated over the course of the 3-day culture from the 8-cell to blastocyst stages. For each of these amino acids, at 250 mOsM, blastocysts had accumulated approximately 5-6 pmoles/embryo by the end of culture (Fig. 5) . We did not test b-alanine, as we did not have it available in 3 H-labeled form. In somatic cells that utilize organic osmolytes for osmoprotection, as well as in 1-cell mouse embryos, organic osmolyte accumulation is stimulated by increased external osmolarity. Thus, we also assessed accumulation at 310 and 340 mOsM. There was, however, no significant difference in total accumulated alanine, glutamine, or glycine with increased osmolarity (Fig. 5) , despite the observed rescue of blastocyst volume at these osmolarities.
The accumulation of these potential organic osmolytes in blastocysts implied that they were transported into the cells of the embryos during development from the 8-cell to blastocyst stages. To determine what transporter(s) could be responsible, we tested a series of possible competitive inhibitors of transport in morulae, which is the stage that would likely have to accumulate organic osmolytes to protect embryo development into blastocysts. The rate of transport was measured using a 10-min incubation with 1 lM 3 H-labeled compounds, and the effect of the presence of 10 mM unlabeled compounds was assessed (Fig. 6) . Alanine transport was entirely saturable, as indicated by the complete inhibition by excess unlabeled alanine. Its transport was also completely inhibited by leucine, lysine, and BCH (2-amino-endo-bycyclo[2.2.1]heptane-2-carboxylic acid). These competitive inhibitors were chosen to target B 0,þ , a transport system that is activated in embryos near compaction and becomes highly active in blastocysts. B 0,þ has a characteristic ability to transport both neutral and cationic amino acids and to accept BCH [35] .
Glutamine transport was also almost entirely saturable and significantly inhibited by leucine, lysine, and BCH (Fig. 6 ). In addition, glycine significantly inhibited glutamine transport. Because glycine is accepted as a substrate both by B 0,þ and by the GLY transporter, which is highly active in early cleavagestage embryos [22] , we also tested whether the specific GLY inhibitor ORG23798 [24] blocked glutamine transport but did not find significant inhibition. H-labeled amino acid (alanine, glutamine, or glycine, as indicated), after which the total amount of amino acid that had been accumulated was determined. Each bar is the mean 6 SEM of five repeats. There were no significant differences (1-way ANOVA) between osmolarities for any amino acid.
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Glycine transport similarly was saturable and substantially blocked by leucine and lysine and appeared partially inhibited by BCH, although this was not significant (Fig. 6) . Glutamine did not inhibit transport. However, the GLY inhibitor ORG23798 reduced transport by more than half, to a rate that was not significantly different from either the control group or nonspecific transport in the presence of excess unlabeled glycine. These results point to a possible mixed transport by B 0,þ and by GLY (see Discussion).
Finally, although we did not measure b-alanine transport directly, we assessed 3 H-taurine transport (Fig. 6) because the b-amino acid transport system, which is present throughout preimplantation mouse embryo development [18] , accepts balanine and taurine with similar affinities. Taurine transport was entirely saturable and was completely blocked by excess b-alanine, consistent with the expected presence of transport by the b-amino acid transport system. Taurine transport was resistant to leucine, indicating no interaction with B 0,þ .
DISCUSSION
The maturing mouse oocyte and cleavage-stage preimplantation embryo have novel mechanisms for controlling their cell volumes that depend on accumulating organic osmolytes. These include a glycine-dependent mechanism utilizing the GLY transporter [24] and a betaine/proline-dependent mechanism utilizing the SIT1 transporter [19, 20] . However, both of these become inactivated before compaction and formation of the blastocyst. Herein, we have undertaken investigations to determine whether organic compounds that function as organic osmolytes in cleavage-stage embryos or in mammalian somatic cells have similar osmoprotective compounds in postcompaction embryos.
Blastocyst formation from 8-cell embryos in vitro was detrimentally affected by increased osmolarity, but a consistent decrease in blastocoel formation occurred only at osmolarities above the physiological range. Blastocyst development, defined by the formation of a blastocoel of any size, was decreased when osmolarity was raised above 360 mOsM, while the osmolarity of mouse uterine fluid is reported to be 330 mOsM [30] . However, when the volumes of the blastocysts were measured, rather than simply scoring development of any visible blastocoel cavity (i.e., initiation of cavitation), a significant decrease in total blastocyst volume was evident at 310 mOsM and above, well within the range of osmolarities experienced by embryos in vivo, indicating that under some conditions physiological levels of osmolarity may be detrimental to optimal blastocyst development.
Development of blastocysts from 8-cell embryos at increased osmolarities was rescued by the presence of alanine, glutamine, or glycine or high levels of b-alanine. Each of these restored blastocyst formation up to 370 mOsM. The ability of these putative organic osmolytes to rescue blastocyst formation from the highly deleterious effects of moderate hypertonic stress (370 mOsM) was clear, with the proportion reaching the blastocyst stage increasing from about 10% to near 100% after 3 days in culture. H-labeled amino acid) was measured as described in the text. For each amino acid, the presence of saturable transport was demonstrated by comparing the rate of transport in the absence of any addition (none) to an excess (10 mM) of the same unlabeled amino acid (second bar in each panel). Other potential competitive inhibitors, as indicated at the bottom of each panel, were tested for their effects on transport. For alanine and taurine, each bar represents the mean 6 SEM of five repeats. For glutamine and glycine, each bar represents the mean 6 SEM of five repeats except for the last two bars (Gly or Gln and ORG23798), with three repeats; the first two bars in these panels contain an additional three repeats that were done in parallel, for eight total. Within each panel, bars that do not share the same letters are significantly different (P , 0.05 by ANOVA with Tukey-Kramer post hoc test).
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Each of the osmoprotective compounds identified resulted in increased total blastocyst volume in media with moderately increased osmolarities in the physiological range (310-340 mOsM). This is likely principally due to increased blastocoel expansion rather than an effect on cell proliferation or cell death because an effect on total cell number was not seen at 310 mOsM and the proportion of apoptotic nuclei, although increased at 340 and 370 mOsM, was not rescued by glycine. At more extreme levels of hypertonic stress (370 mOsM), an additional effect on cell number became evident, which was rescued by the presence of any of the osmoprotective compounds identified herein. It is possible that the detrimental effect on expansion is due to an inhibition of metabolic energy production or transtrophectodermal fluid transport at physiological osmolarities that is restored by the presence of organic osmolytes, but this remains to be investigated.
Our results imply that the accumulation of these osmoprotective compounds, likely as a mixture taken up from uterine fluid, would be required to support maximal blastocyst expansion in vivo and would confer similar protection in in vitro environments whose osmolarity approximates that of their normal in vivo environment, including culture systems. Thus, organic osmolytes such as these would appear to be required to support optimal development under physiological conditions. In addition, embryos are subject to stresses both in vitro and in vivo, which can include osmotic stresses due to changes in culture conditions, during cryopreservation, and from perturbations of cell volume due to changes in the intracellular concentration of osmotically active compounds arising from metabolism and transmembrane transport. Even quite moderate levels of stress activate the stress kinase response in postcompaction embryos and result in physiological changes in the resulting blastocysts [36] . Our results also imply that intracellular accumulation of osmoprotective compounds should protect against moderate stress, both transient and long term, which can be experienced by embryos in vivo or in vitro.
The results reported herein support the hypothesis that alanine, glutamine, glycine, and b-alanine can have a function in postcompaction embryos similar to that of organic osmolytes in other cells, protecting total blastocyst volume, embryo development, and cell number from the deleterious effects of osmolarity. The initial assay we used to screen for osmoprotection relied on detecting rescue from substantial hypertonicity (400 mOsM) from a set of candidate compounds. Thus, we would not have detected more modest osmoprotective abilities of the compounds that were tested and found ineffective (betaine, proline, myoinositol, and taurine). Nor, of course, can we rule out the existence of other compounds equally osmoprotective in postcompaction embryos that we have not tested. Nevertheless, at least alanine, glutamine, and glycine, which are all substrates of the same transport system in blastocysts (see herein), and high (likely superphysiological) levels of b-alanine clearly have beneficial effects on development of mouse embryos from the 8-cell stage to blastocysts related to their ability to counter the detrimental effects exerted by even physiological levels of osmolarity.
We interpret the osmoprotective effects of these compounds to be due to a phenomenon similar to that of organic osmolyte accumulation in other cells, including those of earlier stages of embryos. This is consistent with their essentially interchangeable osmoprotective effects at each osmolarity tested and with their intracellular accumulation by embryos to high levels during development from the 8-cell stage to blastocysts. They do not, however, exhibit all of the characteristics associated with organic osmolytes in other cells, as they were not accumulated to higher intracellular levels with increasing osmolarity, a classic property of organic osmolytes exhibited in somatic cells and earlier stages of embryos. Such increased accumulation is thought to displace the additional inorganic ions that would otherwise be needed to balance increased external osmolarity, hence keeping intracellular ionic strength essentially constant. There are at least two possibilities to account for the observed lack of increased total accumulation in postcompaction embryos. The baseline accumulation in blastocysts even at lower osmolarities (e.g., at 250 mOsM in Fig. 5 ) could be sufficient to displace enough intracellular inorganic ions to allow the range of osmolarities permissive for development to be extended, without the need for additional organic osmolyte accumulation above this level. Alternatively, total intracellular volume could be lower in blastocysts at increased osmolarities, so that the intracellular concentration of accumulated osmolytes is actually higher, despite the lack of increase in the total amounts measured per embryo.
With the exception of b-alanine, which is transported by the b-amino acid transporter that is active throughout preimplantation development, the osmoprotective compounds were each confirmed to be substrates of the B 0,þ transporter, which starts to become active beginning at the 8-cell stage and is highly active in blastocysts. We measured transport characteristics under our conditions in morulae, during the period of accumulation, and found that alanine transport was entirely by B 0,þ , while glutamine and glycine were at least partly transported by B 0,þ , with the remainder likely due to residual activity of the glycine transporter, GLY. Because B 0,þ activity increases greatly between the morula and blastocyst stages [35] , while, in contrast, GLY is highly active in cleavage-stage embryos, almost quiescent in morulae, and absent from blastocysts [22, 27] , the osmoprotective effect of alanine, glutamine, and glycine on development from the 8-cell stage is most likely due to their transport via B 0,þ . The lack of osmoprotective effect by betaine and myoinositol argues against significant roles for the somatic cell organic osmolyte transporters BGT1 and Na þ -myoinositol transporter. A role for system A is ruled out by the lack of a component of alanine transport that is not inhibited by lysine or BCH, as these are not system A substrates.
We have found herein that compounds transported into postcompaction embryos, including alanine, glutamine, glycine, and b-alanine, are beneficial for blastocyst development at least in part due to their ability to counter deleterious effects of osmolarity, including in the physiological range. That the first three are all substrates of the B 0,þ transport system, which only becomes active after compaction, emphasizes the functional connection between developmental changes in transporters in preimplantation embryos and their physiological needs. B 0,þ has not previously been implicated to be an organic osmolyte transporter or to have an osmoprotective role in any cell type, to our knowledge. Finally, the postcompaction mouse embryo provides an unusual example of a system that apparently benefits from organic osmolyte accumulation without accumulation increasing as osmolarity increases, unlike in other cells.
